World watches as first person receives Pfizer-BioNTech COVID shot

Manufacturing delays mean just 4 million doses of the vaccine candidate being developed by drugmaker AstraZeneca
AZN,
+0.97%
and the University of Oxford will be delivered to the U.K., falling short of the 30 million doses the country had hoped to receive by the end of the year.

News of the shortfall comes as the U.K. became the first country to embark on a mass immunization program, with National Health Service hospitals on Tuesday starting to administer 800,000 shots of the vaccine developed by U.S. drugmaker Pfizer
PFE,
+2.26%
and its German partner BioNTech
BNTX,
+4.75%.